AIMC Topic: Drug Discovery

Clear Filters Showing 601 to 610 of 1550 articles

Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.

International journal of molecular sciences
The discovery and advances of medicines may be considered as the ultimate relevant translational science effort that adds to human invulnerability and happiness. But advancing a fresh medication is a quite convoluted, costly, and protracted operation...

Transformer-based deep learning method for optimizing ADMET properties of lead compounds.

Physical chemistry chemical physics : PCCP
A successful drug needs to exhibit both effective pharmacodynamics (PD) and safe pharmacokinetics (PK). However, the coordinated optimization of PD and PK properties in molecule generation tasks remains a great challenge for most existing methods, es...

Recent Studies of Artificial Intelligence on In Silico Drug Distribution Prediction.

International journal of molecular sciences
Drug distribution is an important process in pharmacokinetics because it has the potential to influence both the amount of medicine reaching the active sites and the effectiveness as well as safety of the drug. The main causes of 90% of drug failures...

Artificial intelligence as a smart approach to develop antimicrobial drug molecules: A paradigm to combat drug-resistant infections.

Drug discovery today
Antimicrobial resistance (AMR) is a silent pandemic with the third highest global mortality. The antibiotic development pipeline is scarce even though AMR has escalated uncontrollably. Artificial intelligence (AI) is a revolutionary approach, acceler...

Explaining Accurate Predictions of Multitarget Compounds with Machine Learning Models Derived for Individual Targets.

Molecules (Basel, Switzerland)
In drug discovery, compounds with well-defined activity against multiple targets (multitarget compounds, MT-CPDs) provide the basis for polypharmacology and are thus of high interest. Typically, MT-CPDs for polypharmacology have been discovered seren...

Opportunities and challenges in application of artificial intelligence in pharmacology.

Pharmacological reports : PR
Artificial intelligence (AI) is a machine science that can mimic human behaviour like intelligent analysis of data. AI functions with specialized algorithms and integrates with deep and machine learning. Living in the digital world can generate a hug...

Deep learning in image-based phenotypic drug discovery.

Trends in cell biology
Modern drug discovery approaches often use high-content imaging to systematically study the effect on cells of large libraries of chemical compounds. By automatically screening thousands or millions of images to identify specific drug-induced cellula...

AlphaFold2 protein structure prediction: Implications for drug discovery.

Current opinion in structural biology
The drug discovery process involves designing compounds to selectively interact with their targets. The majority of therapeutic targets for low molecular weight (small molecule) drugs are proteins. The outstanding accuracy with which recent artificia...

On the ability of machine learning methods to discover novel scaffolds.

Journal of molecular modeling
The recent advances in the application of machine learning to drug discovery have made it a 'hot topic' for research, with hundreds of academic groups and companies integrating machine learning into their drug discovery projects. Nevertheless, there ...

Traditional Machine and Deep Learning for Predicting Toxicity Endpoints.

Molecules (Basel, Switzerland)
Molecular structure property modeling is an increasingly important tool for predicting compounds with desired properties due to the expensive and resource-intensive nature and the problem of toxicity-related attrition in late phases during drug disco...